Approvals/TGA/GLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule

Approved

STANDARD

GLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule

KSJ Pharmatech🇦🇺 Therapeutic Goods Administration

Approval Id: 6f6052d3a36daa2b
Product Name: GLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
Artg Id: 370932
Artg Name: GLNEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/ neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
Sponsor: KSJ Pharmatech
Company Detail Path: /organization/ksj-pharmatech-limited
Artg Date: 2022-07-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6f6052d3a36daa2b

Type

Standard